Reyataz and Deafness neurosensory - from FDA reports


Summary

There is no Deafness neurosensory reported by people who take Reyataz yet. This review analyzes which people have Deafness neurosensory with Reyataz. It is created by eHealthMe based on reports from FDA, and is updated regularly.

What to expect?

If you take Reyataz and have Deafness neurosensory, find out what symptoms you could have in 1 year or longer.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Dec, 16, 2017

No report is found.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you have Deafness neurosensory when taking Reyataz?

Expand the study to include all drugs with the same ingredients

Deafness neurosensory and drugs with ingredients of atazanavir sulfate.

Expand the study to include reports from both FDA and eHealthMe

Deafness neurosensory and Reyataz from FDA and eHealthMe reports

Reyataz

Reyataz has active ingredients of atazanavir sulfate. It is often used in hiv infection. (latest outcomes from Reyataz 8,724 users)

Deafness Neurosensory

Deafness neurosensory has been reported by people with osteoporosis, osteopenia, depression, high blood pressure, rheumatoid arthritis (latest reports from 2,551 Deafness neurosensory patients).

Browse all side effects of Reyataz

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Deafness neurosensory

Deafness neurosensory

Could your condition cause Deafness neurosensory

Deafness neurosensory

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Reyataz and have Deafness neurosensory.